Schmidinger M - Search Results

1

Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study.

Motzer RJ, Porta C, Eto M, Powles T, Grünwald V, Hutson TE, Alekseev B, Rha SY, Merchan J, Goh JC, Lalani AA, De Giorgi U, Melichar B, Hong SH, Gurney H, Méndez-Vidal MJ, Kopyltsov E, Tjulandin S, Gordoa TA, Kozlov V, Alyasova A, Winquist E, Maroto P, Kim M, Peer A, Procopio G, Takagi T, Wong S, Bedke J, Schmidinger M, Rodriguez-Lopez K, Burgents J, He C, Okpara CE, McKenzie J, Choueiri TK; CLEAR Trial Investigators. Motzer RJ, et al. Among authors: schmidinger m. J Clin Oncol. 2024 Apr 10;42(11):1222-1228. doi: 10.1200/JCO.23.01569. Epub 2024 Jan 16. J Clin Oncol. 2024. PMID: 38227898 Free PMC article. Clinical Trial.

2

HER2 and TOP2A Gene Amplification and Protein Expression in Upper Tract Urothelial Carcinomas.

Aumayr K, Klatte T, Neudert B, Birner P, Shariat S, Schmidinger M, Susani M, Haitel A. Aumayr K, et al. Among authors: schmidinger m. Pathol Oncol Res. 2018 Jul;24(3):575-581. doi: 10.1007/s12253-017-0260-0. Epub 2017 Jul 28. Pathol Oncol Res. 2018. PMID: 28755093 Free article.

3

[Management of capecitabine-induced hand-foot syndrome by local phytotherapy].

Kern E, Schmidinger M, Locker GJ, Kopp B. Kern E, et al. Among authors: schmidinger m. Wien Med Wochenschr. 2007;157(13-14):337-42. doi: 10.1007/s10354-007-0435-5. Wien Med Wochenschr. 2007. PMID: 17704983 German.

4

Glutathione in the prevention of cisplatin induced toxicities. A prospectively randomized pilot trial in patients with head and neck cancer and non small cell lung cancer.

Schmidinger M, Budinsky AC, Wenzel C, Piribauer M, Brix R, Kautzky M, Oder W, Locker GJ, Zielinski CC, Steger GG. Schmidinger M, et al. Wien Klin Wochenschr. 2000 Jul 28;112(14):617-23. Wien Klin Wochenschr. 2000. PMID: 11008323 Clinical Trial.

5

Docetaxel monotherapy in heavily pretreated metastatic breast cancer: a multicenter, community-based feasibility trial.

Schmidinger M, Budinsky AC, Wenzel C, Locker GJ, Pluschnig U, Brodowicz T, Kubista E, Maca S, Zabernigg A, Ilsinger P, Seewann L, Hojas S, Blach M, Zielinski CC, Steger GG. Schmidinger M, et al. Cancer Chemother Pharmacol. 2001;47(1):57-62. doi: 10.1007/s002800000204. Cancer Chemother Pharmacol. 2001. PMID: 11221963

6

[Aerobic endurance training for cancer patients].

Crevenna R, Zielinski C, Keilani MY, Schmidinger M, Bittner C, Nuhr M, Nur H, Marosi C, Fialka-Moser V, Quittan M. Crevenna R, et al. Among authors: schmidinger m. Wien Med Wochenschr. 2003;153(9-10):212-6. doi: 10.1046/j.1563-258x.2003.02080.x. Wien Med Wochenschr. 2003. PMID: 12836458 Review. German.

7

[Aerobic physical training in a breast cancer patient with inflammatory recurrence].

Crevenna R, Fialka-Moser V, Keilani MY, Schmidinger M, Marosi C, Quittan M. Crevenna R, et al. Among authors: schmidinger m. Wien Med Wochenschr. 2002;152(21-22):581-4. doi: 10.1046/j.1563-258x.2002.01135.x. Wien Med Wochenschr. 2002. PMID: 12506684 German.

8

Quality of life in patients with non-metastatic differentiated thyroid cancer under thyroxine supplementation therapy.

Crevenna R, Zettinig G, Keilani M, Posch M, Schmidinger M, Pirich C, Nuhr M, Wolzt M, Quittan M, Fialka-Moser V, Dudczak R. Crevenna R, et al. Among authors: schmidinger m. Support Care Cancer. 2003 Sep;11(9):597-603. doi: 10.1007/s00520-003-0474-4. Epub 2003 Jun 3. Support Care Cancer. 2003. PMID: 12783288

9

[Clinical phase II-evaluation of neoadjuvant, cytostatic combination chemotherapy with docetaxel and epidoxorubicin in female breast cancer patients (T1-4, N0-2, M0)].

Wenzel C, Schmidinger M, Locker GJ, Taucher S, Gnant M, Jakesz R, Steger GG. Wenzel C, et al. Among authors: schmidinger m. Wien Klin Wochenschr. 1999 Oct 29;111(20):843-50. Wien Klin Wochenschr. 1999. PMID: 10586489 Clinical Trial. German.

10

CD98hc (SLC3A2), a novel marker in renal cell cancer.

Prager GW, Poettler M, Schmidinger M, Mazal PR, Susani M, Zielinski CC, Haitel A. Prager GW, et al. Among authors: schmidinger m. Eur J Clin Invest. 2009 Apr;39(4):304-10. doi: 10.1111/j.1365-2362.2009.02096.x. Eur J Clin Invest. 2009. PMID: 19292886

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

161 results

Search Page

Filters